Impacts of robotic surgery in the treatment of uterine myomatosis: Outcomes and complications
PDF (Português (Brasil))

Keywords

Robotic surgery;
Myoma;
Myomectomy;
Leiomyoma.

How to Cite

dos Santos Medeiros, M. M., Barbalho Filho, E. P., Cordeiro de Almeida, G. V., Augusta de Melo, K. F., Nunes, I. de S., Menezes Heitor, K. C., Rosa de Albuquerque, M. C., Souza, L. S., Cordeiro de Almeida, C., Damaso Lisboa Costa, M. D., Torres Magalhães, A., & Araújo de Lira, R. L. (2024). Impacts of robotic surgery in the treatment of uterine myomatosis: Outcomes and complications. Brazilian Journal of Implantology and Health Sciences, 6(7), 1497–1506. https://doi.org/10.36557/2674-8169.2024v6n7p1497-1506

Abstract

Introduction: Leiomyomas are the most common tumors of the uterus and pelvis. They have high morbidity and constitute the majority of surgical indications in gynecology. In order to preserve the fertility of young women and ensure a less traumatic procedure, robotic surgery has emerged as an effective technique in the treatment of this pathology.  Methodology: An inactive review was carried out in the PubMed and Virtual Health Library databases, with the guiding research question: What are the impacts of robotic surgery in the treatment of uterine myomatosis? The descriptors “robotic surgery” and “myomectomy” were used. 16 publications were used between 2014 and 2014, without any language restrictions. Results and Discussion: Robotic surgery provides better results compared to open surgery. It consists of less bridle formation, less blood loss, less hospital stay and complications. It is capable of removing a greater number of tumors and progressing in unfavorable locations. Compared to laparoscopic surgery, the robotic modality did not demonstrate significant differences when performed by a qualified gynecological surgeon and with a large patient flow. There were no different results, although robotic surgery involved greater time and costs. Conclusion: Even with increasing use, the application of robotic surgery faces challenges. The advantages of this surgical modality were not sufficient to make it the gold standard in the treatment of uterine myomatosis when compared to laparoscopy.

https://doi.org/10.36557/2674-8169.2024v6n7p1497-1506
PDF (Português (Brasil))

References

WON, S. et al. Comparison of cesarean delivery outcome after robotic and laparoscopic myomectomy. Taiwanese Journal of Obstetrics & Gynecology, v. 62, n. 1, p. 12–15, 1 jan. 2023.

LONNERFORS, C. Robot-assisted myomectomy. Best Practice & Research Clinical Obstetrics & Gynaecology, v. 46, p. 113–119, jan. 2018.

GOLDBERG, H. R. et al. Fertility and Pregnancy Outcomes After Robotic-assisted Laparoscopic Myomectomy in a Canadian Cohort. Journal of Minimally Invasive Gynecology, v. 29, n. 1, p. 72–76, jan. 2022.

AHN, S. H. et al. Robotic single-site versus multi-port myomectomy: a case–control study. BMC Surgery, v. 21, n. 1, 27 maio 2021.

LIM, P. C. et al. Multicenter analysis comparing robotic, open, laparoscopic, and vaginal hysterectomies performed by high-volume surgeons for benign indications. International Journal of Gynecology & Obstetrics, v. 133, n. 3, p. 359–364, 16 fev. 2016.

FEGRASGO (Federação Brasileira das Associações de Ginecologia e Obstetrícia). Tratado de Ginecologia. Edição e revisão técnica: Angelo Alves de Mattos Filho, Eliane Santos, Frederico Peret, Francisco José Candido dos Reis, Francisco Edson de Lucena Feitosa, Francisco das Chagas Medeiros, Frederico Barroso, Frederico Pires, et al. Rio de Janeiro: Elsevier, 2019.

Herrmann, A. and De Wilde, R.L. Laparoscopic Myomectomy—The Gold Standard. Gynecology and Minimally Invasive Therapy, v. 3, p. 31-38, jan 2014.

WANG, T. et al. Robotic-assisted vs. laparoscopic and abdominal myomectomy for treatment of uterine fibroids: a meta-analysis. Minimally Invasive Therapy & Allied Technologies, v. 27, n. 5, p. 249–264, 28 fev. 2018.

MUKUNDA, S. B.; SHEN, Y.; SUGANDHA, S. Benefits and Limitations of Laparoscopic Myomectomy. Open Journal of Obstetrics and Gynecology, v. 09, n. 03, p. 292–301, 2019.

PARK, K.-M. et al. Variables that prolong total operative time for robotic-assisted laparoscopic myomectomy: A 10-year tertiary hospital study in Korea. Eur J Obstet Gynecol Reprod Biol, p. 62–67, 2021.

CHENG, H.-Y. et al. Robotic-assisted laparoscopic complex myomectomy: A single medical center’s experience. Taiwanese Journal of Obstetrics and Gynecology, v. 54, n. 1, p. 39–42, fev. 2015.

MOON, H. S.; JEONG, K.; LEE, S. R. Robotic-assisted single incision myomectomy in large myoma cases. Clinical and experimental obstetrics & gynecology, v. 44, n. 2, p. 283–287, 10 abr. 2017.

KIM, J.-H.; LEE, E.-J. Single-Site Robotic Myomectomy without Accessory Instrument Compared with Two-Port Laparoscopic Myomectomy: A Propensity Score Matching Analysis. Gynecologic and obstetric investigation, v. 87, n. 1, p. 70–78, 1 jan. 2022.

ALKHRAIT, S. et al. Surgical myomectomy followed by oral Myfembree vs standard of care (SOUL trial): Study protocol for a randomized control trial. PLoS One, p. e0306053–e0306053, 2024.

TABATABAEI, F. et al. Comparison of uterine myometrial thickness at the site of myomectomy scar after surgery using laparoscopic and laparotomy methods. J Robot Surg, p. 270–270, 2024.

KRZYZANOWSKI, J. et al. Advancements and Emerging Therapies in the Medical Management of Uterine Fibroids: A Comprehensive Scoping Review. Med Sci Monit, p. e943614–e943614, 2024.

TRIVEDI, S. et al. Disseminated peritoneal leiomyoma: a diagnostic dilemma. BMJ Case Rep, 2024.

HE, Y. et al. Feasibility, safety and efficacy of high intensity focused ultrasound ablation as a preoperative treatment for challenging hysteroscopic myomectomy. Int J Hyperthermia, p. 2365974–2365974, 2024.

MARJORIBANKS, J.; LETHABY, A.; FARQUHAR, C. Surgery versus medical therapy for heavy menstrual bleeding. The Cochrane Database of Systematic Reviews, n. 2, p. CD003855, 2003.

DAVIS, M. R. et al. Reintervention Rates After Myomectomy, Endometrial Ablation, and Uterine Artery Embolization for Patients with Uterine Fibroids. Journal of Women’s Health, v. 27, n. 10, p. 1204–1214, out. 2018.

MITRO, S. D. et al. Long-Term Risk of Reintervention After Surgical Leiomyoma Treatment in an Integrated Health Care System. Obstetrics and Gynecology, v. 143, n. 5, p. 619–626, 1 maio 2024.

AMOAH, A.; QUINN, S. D. Uterine‐preserving treatments or hysterectomy reintervention after myomectomy or uterine artery embolisation: A retrospective cohort study of long‐term outcomes. BJOG: An International Journal of Obstetrics and Gynaecology, v. 130, n. 7, p. 823–831, 15 fev. 2023.

BORAH, B. J. et al. Comparative Effectiveness of Uterine Leiomyoma Procedures Using a Large Insurance Claims Database. Obstetrics & Gynecology, v. 130, n. 5, p. 1047–1056, nov. 2017.

MOURAD, A. et al. Enhancing surgical performance: the role of robotic surgery in myomectomies, a systematic review and metanalysis. J Robot Surg, p. 184–184, 2024.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Myckanne Mirelle dos Santos Medeiros, Eli Pinto Barbalho Filho, Guilherme Vitor Cordeiro de Almeida, Katiane Fernanda Augusta de Melo, Isaac de Santana Nunes, Keila Cristina Menezes Heitor, Mayara Cavalcanti Rosa de Albuquerque, Laura Stankowich Souza, Caroline Cordeiro de Almeida, Marcelo Danilo Damaso Lisboa Costa, Alexandre Torres Magalhães, Rayra Luiza Araújo de Lira